Dugast Sophie, Longis Julie, Anquetil Marine, Corre Pierre, Komarova Svetlana, Bertin Hélios
Department of Maxillofacial Surgery and Stomatology, Nantes Université, CHU Nantes, Nantes, France.
Nantes Université, Oniris, Univ Angers, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, RMeS, UMR 1229, Nantes, France.
Head Neck. 2025 Apr;47(4):1277-1290. doi: 10.1002/hed.28059. Epub 2024 Dec 31.
Dental implantation of bone reconstructions in oncologic situations improves patients' orofacial function and quality of life. There are currently no recommendations on the timing of implantation.
This systematic review with meta-analysis aimed to compare primary and secondary dental implantation of free bone flaps in reconstructions for malignant tumors of the oral cavity. The primary objective was to evaluate the implant survival rate, with secondary criteria including time to prosthesis placement, postoperative complications, and data on quality of life. Results-Three databases were screened for articles published between January 1990 and April 2024. Out of 2438 studies, 16 met the eligibility criteria, encompassing 284 patients. In total, 319 implants were placed in the primary implantation group and 1108 in the second group. Implant survival rate was 92.5% in the primary implantation group compared to 88.5% in the secondary implantation group. This systematic review underscores a higher success rate for implants placed primarily in patients with oral cancer.
Given the rapid functional and aesthetic improvement offered by prosthetic rehabilitation, primary implantation should be systematically considered in the oncological population.
在肿瘤情况下进行牙种植骨重建可改善患者的口面部功能和生活质量。目前对于种植时机尚无相关建议。
本项带有荟萃分析的系统评价旨在比较口腔恶性肿瘤重建中游离骨瓣的一期和二期牙种植。主要目的是评估种植体存活率,次要标准包括安装假体的时间、术后并发症以及生活质量数据。结果:检索了三个数据库中1990年1月至2024年4月发表的文章。在2438项研究中,16项符合纳入标准,涉及284例患者。一期种植组共植入319颗种植体,二期种植组共植入1108颗。一期种植组的种植体存活率为92.5%,而二期种植组为88.5%。本系统评价强调,对于口腔癌患者,一期种植的成功率更高。
鉴于修复性康复能迅速改善功能和美观,肿瘤患者应系统性地考虑一期种植。